Literature DB >> 2765356

Human microvessel endothelial cell isolation and vascular graft sodding in the operating room.

S K Williams1, B E Jarrell, D G Rose, J Pontell, B A Kapelan, P K Park, T L Carter.   

Abstract

We have evaluated multiple factors inherent to an operating room-compatible endothelial cell procurement and sodding procedure. Microvessel endothelial cell isolations have been performed on fat tissue obtained from over 140 patients with a 100% success rate. Liposuction-derived fat was optimal with respect to cell yield, and isolation time. The devices and equipment used were acceptable to the operating room and the complete cell procurement procedure was successful even in the hands of personnel with minimal training. Fat digestion was achieved using crude clostridial collagenase, with an average cell yield of 1 x 10(6) microvessel endothelial cells/gm of fat. Evaluation of this procedure with canine fat using an operating room acceptable procedure resulted in a 100% procurement success rate requiring 1.5 hours (+/- .5 hrs) for completion of the fat isolation, and cell isolation procedure. Microvessel EC could subsequently be used in graft seeding or sodding techniques to establish endothelial cell monolayers on vascular grafts. Our results indicate that one person with minimal cell isolation background can reproducibly isolate large quantities of sterile autologous endothelial cells in the operating room for immediate use in endothelial cell seeding/sodding procedures.

Entities:  

Mesh:

Year:  1989        PMID: 2765356     DOI: 10.1016/S0890-5096(06)62008-6

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  9 in total

Review 1.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

2.  Selective cell proliferation can be controlled with CPC particle coatings.

Authors:  J A Szivek; D S Margolis; A B Schnepp; W A Grana; S K Williams
Journal:  J Biomed Mater Res A       Date:  2007-06-15       Impact factor: 4.396

Review 3.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

Review 4.  The Adipose Stromal Vascular Fraction as a Complex Cellular Source for Tissue Engineering Applications.

Authors:  Venkat M Ramakrishnan; Nolan L Boyd
Journal:  Tissue Eng Part B Rev       Date:  2017-04-13       Impact factor: 6.389

5.  Availability of adipose-derived stem cells in patients undergoing vascular surgical procedures.

Authors:  Lisa J Harris; Ping Zhang; Hamid Abdollahi; Nicholas A Tarola; Christopher DiMatteo; Stephen E McIlhenny; Thomas N Tulenko; Paul J DiMuzio
Journal:  J Surg Res       Date:  2010-05-10       Impact factor: 2.192

6.  Isolation and characterization of microvessel endothelial cells from human mammary adipose tissue.

Authors:  P W Hewett; J C Murray; E A Price; M E Watts; M Woodcock
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

Review 7.  Human microvessel endothelial cells: isolation, culture and characterization.

Authors:  P W Hewett; J C Murray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

8.  Wnt5a Regulates the Assembly of Human Adipose Derived Stromal Vascular Fraction-Derived Microvasculatures.

Authors:  Venkat M Ramakrishnan; Kevin T Tien; Thomas R McKinley; Braden R Bocard; Terry M McCurry; Stuart K Williams; James B Hoying; Nolan L Boyd
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

9.  Adipose-Derived Stromal Vascular Fraction Cell Effects on a Rodent Model of Thin Endometrium.

Authors:  Robert K Hunter; Chris D Nevitt; Jeremy T Gaskins; Bradley B Keller; Henry C L Bohler; Amanda J LeBlanc
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.